Interleukin 10 and clustering of metabolic syndrome components in pediatrics.

dc.contributor.advisor	Jung-Su Chang
dc.contributor.advisor	Chyi-Huey Bai
dc.contributor.advisor	Zu-Chieh Huang
dc.contributor.advisor	Eddy Owaga
dc.contributor.advisor	Kuo-Ching Chao
dc.contributor.advisor	Chun-Chao Chang
dc.contributor.advisor	Hung-Yi Chiou
dc.date.accessioned	Eddy Owaga1 Jung-Su Chang1, Chyi-Huey Bai2, Zu-Chieh Huang1, , Kuo-Ching Chao3,4, Chun-Chao Chang3,4 andHung-Yi Chiou5,*
dc.date.available	2015-09-16T11:29:46Z
dc.date.issued	2014
dc.identifier.uri	http://41.89.227.156:8080/xmlui/handle/123456789/386
dc.description.abstract	Interleukin 10 (lL-10) has multifaceted anti-inflammatory properties that are known to regulate insulin sensitivity and atherosclerotic development. However, studies in children are limited and have yielded Conflicting results. The aim of this study was to evaluate whether changes in this circulating anti-inflammatory cytokine is a marker for metabolic syndrome. Materials and methods This cross-sectional study involved children and young adolescents from eight elementary schools and two junior high schools located in Taipei end New Taipei City. A total of 553 children ages 8, 11 and 13 years old were included in the analysis. Parameters for obesity, anti- and pro-inflammatory cytokines, and metabolic risk profiles were evaluated.	en_US
dc.language.iso	en	en_US
dc.title	Interleukin 10 and clustering of metabolic syndrome components in pediatrics.	en_US
dc.type	Article	en_US